case_images: PMC4899653_01
case_images: Intralenticular location of Ozurdex immediately after the injection.
case_images: cop-0007-0085-g01.jpg
case_images: PMC4899653_01_cop-0007-0085-g01.jpg
case_images: F1
case_images: However, the implant accidentally caused a posterior capsular tear and was injected into the crystalline lens because of an involuntary head movement of the patient during the procedure (fig. 1).
case_images: Optical coherence tomography of the right eye. a Before the injection. b Improvement of the macular edema 6 months after the injection.
case_images: cop-0007-0085-g02.jpg
case_images: PMC4899653_01_cop-0007-0085-g02.jpg
case_images: F2
case_images: CMT and BCVA were 253 microm and 58 letters at the first month, 262 microm and 56 letters at the third month and 254 microm and 48 letters at the sixth month (fig. 2).
case_images: Intralenticular location of Ozurdex and cataract development 4 months after the injection.
case_images: cop-0007-0085-g03.jpg
case_images: PMC4899653_01_cop-0007-0085-g03.jpg
case_images: F3
case_images: Macular edema resolved within time, while BCVA did not show significant improvement due to an increase in lens opacification (fig. 3).